188 related articles for article (PubMed ID: 36059951)
1. Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study.
Ye Q; Yu X; Chen W; Li M; Gu S; Huang L; Zhan Q; Wang C
Front Pharmacol; 2022; 13():972585. PubMed ID: 36059951
[No Abstract] [Full Text] [Related]
2. A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation.
Van Daele R; Bekkers B; Lindfors M; Broman LM; Schauwvlieghe A; Rijnders B; Hunfeld NGM; Juffermans NP; Taccone FS; Coimbra Sousa CA; Jacquet LM; Laterre PF; Nulens E; Grootaert V; Lyster H; Reed A; Patel B; Meersseman P; Debaveye Y; Wauters J; Vandenbriele C; Spriet I
Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361978
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study.
Ronda M; Llop-Talaveron JM; Fuset M; Leiva E; Shaw E; Gumucio-Sanguino VD; Diez Y; Colom H; Rigo-Bonnin R; Puig-Asensio M; Carratalà J; Padullés A
Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508196
[TBL] [Abstract][Full Text] [Related]
4. Fluctuating Voriconazole Concentrations during Extracorporeal Membrane Oxygenation.
Vu T; Feih J; Juul J
J Pharm Pract; 2023 Aug; 36(4):998-1001. PubMed ID: 35612553
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation.
Lin XB; Hu XG; Xia YZ; Liu XM; Liang T; Chen X; Cai CJ
J Chemother; 2022 Jul; 34(4):272-276. PubMed ID: 34904531
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
Spriet I; Annaert P; Meersseman P; Hermans G; Meersseman W; Verbesselt R; Willems L
J Antimicrob Chemother; 2009 Apr; 63(4):767-70. PubMed ID: 19218271
[TBL] [Abstract][Full Text] [Related]
7. Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report.
Peterson EL; Chittick PJ; Richardson CL
Transpl Infect Dis; 2021 Jun; 23(3):e13545. PubMed ID: 33316840
[TBL] [Abstract][Full Text] [Related]
8. Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients.
Bienvenu AL; Pradat P; Plesa A; Leclerc V; Piriou V; Fellahi JL; Argaud L; Rimmelé T; Menotti J; Aubrun F; Richard JC; Gagnieu MC; Parant F; Chidiac C; Leboucher G; Tod M; Goutelle S
PLoS One; 2021; 16(11):e0260656. PubMed ID: 34818379
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
Hahn J; Choi JH; Chang MJ
J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Vancomycin Dosing Guided by Therapeutic Drug Monitoring in Adult Patients Receiving Extracorporeal Membrane Oxygenation.
Marella P; Roberts J; Hay K; Shekar K
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571814
[TBL] [Abstract][Full Text] [Related]
12. Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
Li H; Li M; Yan J; Gao L; Zhou L; Wang Y; Li Q; Wang J; Chen T; Wang T; Zheng J; Qiang W; Zhang Y; Shi Q
Basic Clin Pharmacol Toxicol; 2020 Dec; 127(6):495-504. PubMed ID: 32639669
[TBL] [Abstract][Full Text] [Related]
13. Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients.
Zheng L; Alshaer MH; Peloquin C; Venugopalan V; Alnuaimat HM; Converse M
Pulm Pharmacol Ther; 2024 Mar; 84():102271. PubMed ID: 38008397
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung Aspergillosis: A Case Report.
Mathieu A; Thiboutot Z; Ferreira V; Benoit P; Grandjean Lapierre S; HÉtu PO; Halwagi A
ASAIO J; 2022 Mar; 68(3):e56-e58. PubMed ID: 33788798
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing voriconazole plasma level in intensive care patients.
Hinze CA; Fuge J; Grote-Koska D; Brand K; Slevogt H; Cornberg M; Simon S; Joean O; Welte T; Rademacher J
JAC Antimicrob Resist; 2024 Apr; 6(2):dlae045. PubMed ID: 38500519
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study.
Wang T; Miao L; Shao H; Wei X; Yan M; Zuo X; Zhang J; Hai X; Fan G; Wang W; Hu L; Zhou J; Zhao Y; Xie Y; Wang J; Guo S; Jin L; Li H; Liu H; Wang Q; Chen J; Li S; Dong Y
Int J Antimicrob Agents; 2022; 60(5-6):106692. PubMed ID: 36372345
[TBL] [Abstract][Full Text] [Related]
17. Impact of extracorporeal membrane oxygenation (ECMO) support on piperacillin exposure in septic patients: a case-control study.
Fillâtre P; Lemaitre F; Nesseler N; Schmidt M; Besset S; Launey Y; Maamar A; Daufresne P; Flecher E; Le Tulzo Y; Tadie JM; Tattevin P
J Antimicrob Chemother; 2021 Apr; 76(5):1242-1249. PubMed ID: 33569597
[TBL] [Abstract][Full Text] [Related]
18. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study.
Kühn D; Metz C; Seiler F; Wehrfritz H; Roth S; Alqudrah M; Becker A; Bracht H; Wagenpfeil S; Hoffmann M; Bals R; Hübner U; Geisel J; Lepper PM; Becker SL
Crit Care; 2020 Nov; 24(1):664. PubMed ID: 33239110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
